| Dr Benjamin J Cochran, APRN, DNP | |
|
607 E 4th St, Altamont, KS 67330-6427 | |
| (620) 784-2312 | |
| Not Available |
| Full Name | Dr Benjamin J Cochran |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 607 E 4th St, Altamont, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912339672 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 53-76040-072 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Labette Home Health | Parsons, KS | Home health agency |
| Harry Hynes Memorial Hospice | Wichita, KS | Hospice |
| Labette Health | Parsons, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Labette County Medical Center | 5496664369 | 73 |
News Archive
Mount Sinai Health System faculty will be presenting research updates on a lymphoma vaccine clinical trial, the best dosing for a drug against metastatic cancer, and new treatment strategies in relapsed multiple myeloma at the American Society of Clinical Oncology annual meeting, May 29 - June 2, 2015, in Chicago.
Local news accounts detail changes in the market. In Iowa, Wells Fargo employees are choosing between high deductible options, while in Minnesota one insurer is rolling out a new individual policy that may help buoy its position when the state health exchanges begin operation.
Researchers from the Epigenetics and Cancer Biology Program led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic leukemia.
Chronic inhalation of polluted air appears to activate a protein that triggers the release of white blood cells, setting off events that lead to widespread inflammation, according to new research in an animal model.
The Myelin Repair Foundation (MRF) today announced the achievement of a myelin repair Phase 1 clinical trial for multiple sclerosis earlier than the foundation's goal set for 2014. By establishing its Accelerated Research Collaboration (ARC) Model to advance myelin repair treatments forward into clinical trial Phase 1 within a decade, the Myelin Repair Foundation achieved this critical milestone ahead of its goal, validating the efficiency of the ARC model to speed drug development.
› Verified 9 days ago
| Entity Name | Labette County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336133362 PECOS PAC ID: 5496664369 Enrollment ID: O20031112000344 |
News Archive
Mount Sinai Health System faculty will be presenting research updates on a lymphoma vaccine clinical trial, the best dosing for a drug against metastatic cancer, and new treatment strategies in relapsed multiple myeloma at the American Society of Clinical Oncology annual meeting, May 29 - June 2, 2015, in Chicago.
Local news accounts detail changes in the market. In Iowa, Wells Fargo employees are choosing between high deductible options, while in Minnesota one insurer is rolling out a new individual policy that may help buoy its position when the state health exchanges begin operation.
Researchers from the Epigenetics and Cancer Biology Program led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic leukemia.
Chronic inhalation of polluted air appears to activate a protein that triggers the release of white blood cells, setting off events that lead to widespread inflammation, according to new research in an animal model.
The Myelin Repair Foundation (MRF) today announced the achievement of a myelin repair Phase 1 clinical trial for multiple sclerosis earlier than the foundation's goal set for 2014. By establishing its Accelerated Research Collaboration (ARC) Model to advance myelin repair treatments forward into clinical trial Phase 1 within a decade, the Myelin Repair Foundation achieved this critical milestone ahead of its goal, validating the efficiency of the ARC model to speed drug development.
› Verified 9 days ago
| Entity Name | Cancer Center Of Kansas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841251394 PECOS PAC ID: 5395732820 Enrollment ID: O20040427001505 |
News Archive
Mount Sinai Health System faculty will be presenting research updates on a lymphoma vaccine clinical trial, the best dosing for a drug against metastatic cancer, and new treatment strategies in relapsed multiple myeloma at the American Society of Clinical Oncology annual meeting, May 29 - June 2, 2015, in Chicago.
Local news accounts detail changes in the market. In Iowa, Wells Fargo employees are choosing between high deductible options, while in Minnesota one insurer is rolling out a new individual policy that may help buoy its position when the state health exchanges begin operation.
Researchers from the Epigenetics and Cancer Biology Program led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic leukemia.
Chronic inhalation of polluted air appears to activate a protein that triggers the release of white blood cells, setting off events that lead to widespread inflammation, according to new research in an animal model.
The Myelin Repair Foundation (MRF) today announced the achievement of a myelin repair Phase 1 clinical trial for multiple sclerosis earlier than the foundation's goal set for 2014. By establishing its Accelerated Research Collaboration (ARC) Model to advance myelin repair treatments forward into clinical trial Phase 1 within a decade, the Myelin Repair Foundation achieved this critical milestone ahead of its goal, validating the efficiency of the ARC model to speed drug development.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin J Cochran, APRN, DNP Po Box 542, Altamont, KS 67330-0542 Ph: (620) 784-2312 | Dr Benjamin J Cochran, APRN, DNP 607 E 4th St, Altamont, KS 67330-6427 Ph: (620) 784-2312 |
News Archive
Mount Sinai Health System faculty will be presenting research updates on a lymphoma vaccine clinical trial, the best dosing for a drug against metastatic cancer, and new treatment strategies in relapsed multiple myeloma at the American Society of Clinical Oncology annual meeting, May 29 - June 2, 2015, in Chicago.
Local news accounts detail changes in the market. In Iowa, Wells Fargo employees are choosing between high deductible options, while in Minnesota one insurer is rolling out a new individual policy that may help buoy its position when the state health exchanges begin operation.
Researchers from the Epigenetics and Cancer Biology Program led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic leukemia.
Chronic inhalation of polluted air appears to activate a protein that triggers the release of white blood cells, setting off events that lead to widespread inflammation, according to new research in an animal model.
The Myelin Repair Foundation (MRF) today announced the achievement of a myelin repair Phase 1 clinical trial for multiple sclerosis earlier than the foundation's goal set for 2014. By establishing its Accelerated Research Collaboration (ARC) Model to advance myelin repair treatments forward into clinical trial Phase 1 within a decade, the Myelin Repair Foundation achieved this critical milestone ahead of its goal, validating the efficiency of the ARC model to speed drug development.
› Verified 9 days ago
Mrs. Mary Catherine Swearengin, ARNP, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 607 E 4th St, Altamont, KS 67330 Phone: 620-784-2312 Fax: 620-784-2314 |